Skip to main content

RootPath Announces Presentation and Fireside Chat at Built With Biology 2022

RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced that CEO and Co-Founder, Xi Chen, will present an overview of RootPath’s gene synthesis platform PathFinder DNA Assembly™ and Nano Toothpick™ at the Built With Biology Conference on April 13, 2022 at 12:30 pm PDT in Oakland, California.

Susana Donkor, a research associate at RootPath, will participate in a fireside chat at the Built With Biology Conference on April 12, 2022 at 5:25 PM PDT.

About RootPath

RootPath is a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude. Our Molecular Programming-based DNA fragment assembly technology gives researchers and drug developers unprecedented, equitable access to long synthetic genes and their functional readouts. By applying our technology to mine a patient’s immunome, we create truly personalized T cell therapies for solid tumors. Together, with leading partners, we are exploring new applications across multiple industries. We enable biology at scale.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.31
+4.45 (2.17%)
AAPL  261.19
+0.61 (0.23%)
AMD  202.89
-0.48 (-0.24%)
BAC  52.91
+0.14 (0.27%)
GOOG  311.85
+8.29 (2.73%)
META  655.86
+11.08 (1.72%)
MSFT  397.65
-0.81 (-0.20%)
NVDA  188.12
+0.22 (0.12%)
ORCL  153.00
-3.54 (-2.26%)
TSLA  410.77
-0.94 (-0.23%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.